Common GI side effects (affecting more than 1 in 10 people) according to the SmPC: Nausea : The most frequent side effect, reported in approximately 44% of patients in clinical trials, usually most pronounced during the first few weeks and with dose increases Diarrhoea : Affects roughly 30% of users, typically mild to moderate and transient Vomiting : Occurs in about 24% of patients, often associated with eating too quickly or consuming large portions Constipation : Reported in approximately 24% of users, which may require dietary modification or occasional laxative use Abdominal pain or discomfort : Affects around 20% of patients, usually described as cramping or bloating Dyspepsia and reflux : Indigestion and heartburn occur in approximately 9% of users Less common but significant GI effects : Delayed gastric emptying : Whilst this is the intended pharmacological effect, in some cases it can cause persistent nausea, vomiting, and inability to tolerate food Pancreatitis : Has been reported in clinical trials and post-marketing

6d) and increased ferritin expression in AD compared to isogenic brain organoids (Fig
If the website cannot provide coverage information, you can request that they contact your health insurance plan and follow up with an email that outlines your coverage details
4 Reasons Why GLP-1 Users Need Fiber Fiber is an essential part of a balanced diet, but it becomes even more important when digestion slows
The findings of the present study indicated a dose-dependent analgesic effect of liraglutide in MIA OA mice model, with better results than dexamethasone (positive control treatment)